Gopal Snacks Q1 FY27: standalone PAT jumps 409% YoY to ₹12.8 Cr as margins rebuild
PAT +408.9% YoY · revenue +31.1% · margins expanding
₹422.32 Cr
+31.1% YoY
₹12.85 Cr
+408.9% YoY
3.04%
+2.3pp YoY
₹1.03
Gopal Snacks' standalone Q1 FY27 (quarter ended June 30, 2026) revenue from operations came in at ₹422.3 Cr, up 31.1% YoY from ₹322.2 Cr and up a modest 3.1% QoQ from ₹409.6 Cr. Standalone PAT was ₹12.85 Cr against ₹2.52 Cr a year ago (+409% YoY reported; ~+431% on an adjusted basis after stripping the negligible ₹0.22 Cr exceptional gain booked in the year-ago quarter), lifting net margin to 3.04% of total income from just 0.78% in Q1 FY26. There were no exceptional items this quarter, unlike Q4 FY26, which carried a ₹17.49 Cr insurance-claim exceptional gain (part of ₹37.46 Cr received during FY26 against the December 2024 Rajkot fire) that inflated that quarter's PAT to ₹29.95 Cr — the resulting -57.1% QoQ PAT decline is a base-effect from that one-off, not sequential deterioration, and should not be read as weakness.
Q1 FY-2027 vs prior quarters
The scale of the YoY jump reflects how depressed the year-ago base was: Q1 FY26 sat close to breakeven as the company worked through post-fire supply disruption and, per management's November 2025 concall, a deliberate effort to regain lost customer base over 6-7 months while full-year guidance was withdrawn. That window (Nov 2025 plus 6-7 months) lines up with this quarter, and the Rajkot plant's recommissioning in May 2026 (capacity 1,05,233 MTPA) — the first quarter with full supply-chain resumption since the fire — is the operational driver most directly tied to the revenue and margin recovery. No consensus Q1-specific street estimate for Gopal Snacks was found; brokerages had flagged "healthy growth" for FMCG names into Q1 FY27 without a hard number, and analysts separately pencil in 15-20% PAT growth for full FY27 — this quarter's YoY PAT growth runs well ahead of that annualized pace, though the comparison isn't apples-to-apples given the unusually weak year-ago base. Management's 25-26% gross-margin guidance from the same call was not restated in this filing. Separately, the company disclosed a ₹16.55 Cr GST show-cause notice received June 5, 2026, unprovisioned in this statement, and the board used this meeting to re-appoint CMD Bipinbhai Hadvani for a further five-year term (October 2026-September 2031).
The stock went into the print at ₹277.9, up 3.4% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
EPS (basic) ₹1.03 vs ₹0.20 a year ago and ₹2.40 in Q4 FY26 (Q4 boosted by the exceptional gain)
Management has withdrawn its full-year revenue guidance due to operational delays but expects H2 revenue to exceed H1's INR 700 crores as the new Modasa plant ramps up to resolve supply chain issues. While gross margins are guided to remain stable around 25-26%, EBITDA margin guidance is under review pending sales reco
— This quarter: met
W1
Whether the Rajkot capacity ramp (1,05,233 MTPA) drives faster sequential growth beyond this quarter's modest 3.1% QoQ
W2
Outcome/provisioning of the ₹16.55 Cr GST show-cause notice (received Jun 5, 2026) in coming quarters
W3
Whether NPM (3.04% this quarter) keeps normalizing toward pre-fire levels against management's 25-26% gross-margin guidance
Strongest quarter yet, but margin expansion stalls amid inflation
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Hit revenue guidance (highest-ever ₹422.3 Cr). Margin guidance maintained, not upgraded despite strong delivery; indicates management conservatism or embedded inflation concerns.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Delivered strongest revenue on record (₹422.3 Cr, +31% YoY) with gross margin beating guidance (27% vs 25–26%). But EBITDA margin of 7.4% lags FY27 guidance of 8–9%, signalling inflation headwinds and Rajkot ramp-up benefits delayed. Management claims ₹150+ Cr/month run rate post-April disruption, supporting ₹1,800–1,900 Cr FY27 target, but margins remain pressure point. Key risk: price-point category (₹5 SKU still dominant) limits pricing power as inflation persists.
₹422.3 Cr
Revenue · +31.1% YoY₹12.8 Cr
Reported PAT · +409% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Highest-ever quarterly revenue of ₹422.3 Cr
METReported revenue exactly ₹422.3 Cr, confirmed in results and call
31% YoY, 3% sequential growth delivered
METResults show exactly 31.1% YoY, 3.1% QoQ growth
Gross margin 27%, well above prior guided 25–26%
METGross profit ₹114 Cr / ₹422.3 Cr revenue = 27.0%; outperformed guidance
EBITDA margin 7.4%, more than double from Q1 FY26's 4.7%
METDelivered OPM 7.5% consistent with 7.4% EBITDA margin claim; implies strong leverage
Manufacturing efficiency from Rajkot restart will drive Q2+ margin expansion
OVERSTATEDQ1 EBITDA margin 7.4% is below FY27 guidance of 8–9%; benefits not yet visible
Maintain FY27 minimum 20% revenue growth guidance
METNo prior numeric FY27 revenue guidance (withdrawn); now stating ₹1,800–1,900 Cr (implied 20%+ from ₹1,500 Cr FY26 base); credible but conservative range
Sequential PAT decline due to prior quarter's insurance claim, not operations
METPAT QoQ down 57.1%; prior Q had exceptional gain, core PAT improvement real. Margin pressure from inflation (4.2% of 5% passed on, 0.8% taken as P&L hit) evident
Earnings quality
What changed since the last call
Revenue guidance re-established post-withdrawal
UpgradePrior Q guidance withdrawn due to supply chain disruption. Now provided: FY27 ₹1,800–1,900 Cr + minimum 20% growth. Implies H2 ₹450–520 Cr cumulative (vs ₹1,200 Cr inferred prior plan), indicating de-risked execution.
Margin guidance maintained but not upgraded
NeutralEBITDA margin FY27 guided 8–9% (unchanged). Q1 delivered 7.4%, implying Q2–Q4 needs 8.1–9.2% to hit target. Inflation (5% in Q1) plus Rajkot ramp costs suggest execution risk; management holding line rather than raising.
Distributor base and retail touchpoints expanded
UpgradeDistributor count: focus states 567 (Q1 FY27) vs 530 (Q4 FY26); other states 129 vs 110. Retail touchpoints on DMS: 424k (+5% internally). Target: 6 lakh outlets by year-end (from 5.25–5.5 lakh now).
Core market growth trajectory reset to positive
UpgradeQ1 core state growth was flat QoQ due to April disruption (₹12–13 Cr revenue loss). Now ₹150+ Cr/month run rate from May onwards, implying core state targeting ₹100+ Cr/month going forward (vs ~₹75–80 Cr implied prior).
The Q&A
Q&A was probing but management held line credibly. Analysts pressed on margin sustainability (Resha Mehta), core market stalling (Saurabh Beria), Nagpur underutilization (Soham Samanta). Management acknowledged challenges (inflation hit, Nagpur <30% utilization) but countered with structural fixes (DMS, double-service, new products). No evasion on numbers; minor deflection on Maharashtra distributor reduction initially. Tone defensive on margins but confident on recovery trajectory.
FY27 guidance credibility — Nitin, HDFC Securities
AnsweredReaffirmed ₹150+ Cr/month current run rate with minimum 20% growth for FY27. April saw disruption (gas shortage, Gondal-to-Rajkot migration), but May–Jun stable. Post-April, run rate ₹150+ Cr.
Inflation pass-through — Nitin, HDFC Securities
AnsweredQ1 took price hike + grammage reduction; strong brand allows this. Q2 will follow similar steps in line with inflation. Confident due to distribution automation (DMS) offsetting competitive disadvantage.
EBITDA margin guidance — Nitin, HDFC Securities
AnsweredFY27 EBITDA margin between 8% to 9%. Sustainable margin target is 11–11.5% by FY28–29.
Trade spend optimization — Resha Mehta, Green Edge Wealth
AnsweredQ1 trade discounts are 2.5% (down from 3.5%); gap on YoY basis is 0.6–0.7%. Of 5% raw material inflation, passed on 4.2%, absorbed 0.8%.
Market share recovery — Resha Mehta, Green Edge Wealth
PartialFifth consecutive quarter of sequential growth. Reversed historical trend of Q4 weakness. Growth drivers: double service, DMS, new products. 'Worst is behind us.'
Core market performance — Saurabh Beria, Sameeksha Capital
AnsweredApril had ₹12–13 Cr revenue loss due to plant disruption; affected core state only. From May onwards, ₹150+ Cr run rate. Rajkot restart enables double-service speed-up and new product rollouts with higher margins.
Nagpur plant utilization — Soham Samanta, Motilal Oswal
AnsweredIdentified 159 distributors mapped to Nagpur; remapped ~60 to Modasa for logistics cost savings. Adding 250 distributors/year target (vs 300–400 km catchment goal). Momentum in Chhattisgarh, MP, Jharkhand, but focus is structural—regional taste differences (e.g., Sabudana Chivda ₹80–90 lakh/month in Maharashtra only).
Outlet expansion trajectory — Abhishek Mathur, Systematix
AnsweredCurrent: 424k on DMS + ~60–70k uncaptured + ~40–50k indirect wholesale = 5.25–5.5 lakh total outlets. Target: 6 lakh by year-end. Majority expansion in focus markets; modest core state growth (~15k outlets).
A&P spend strategy — Abhishek Mathur, Systematix
AnsweredQ1 A&P spend controlled at 1% of revenue to manage inflation. Budgeted 2.2% annualized. Will increase if inflation eases. Price-point category relies on distribution leverage, not heavy marketing.
Sustainable margin target timeline — Saurabh Beria, Sameeksha Capital
AnsweredSustainable EBITDA 11–11.5%. Ramp-up gradual: FY27 8–9% (exit double-digit), FY28 ~10–11% (exit 11%), mid-FY28–29 reach 11–11.5%.
Organized market penetration in Gathiya — Saurabh Beria, Sameeksha Capital
AnsweredOrganized market still ~35% in Gujarat; unorganized 65%. Transition happening over 3–4 decades, will continue. Gopal is capturing organized growth via distribution.
Maharashtra distributor reversal — Anuj D., Antique Stock Broking
PartialInitially gave focus/other state numbers; then clarified Maharashtra had 194 → 205 → 198 distributors. Minor churn; focus strategy is Vidarbha/Khandesh/Marathwada; Pune/Mumbai remain tough.
Regional brand competitive response — Shirish Pardeshi, Motilal Oswal
AnsweredNo visible churn among regional brands in core state. At national level, Miraj (Rajasthan) shut, restarted; Star brand (Kolhapur) shut. No sustained exits observed.
Other snack category growth drivers — Shirish Pardeshi, Motilal Oswal
AnsweredOther products: Shot Go Noodles, rusks, toast rusk, wafer biscuit, wafer roll, jeera biscuit, washing bar. 5 of 7 planned NPIs are non-palm oil. Sold across geographies but limited to hero products in smaller distributors.
2028 growth and margin targets — Adarsh Mishra, Independent Research
AnsweredMinimum 20% CAGR on revenue going forward. FY27 EBITDA 8–9%, FY28 10–11%, PAT 7–7.5%. Exit rates progress toward 11–11.5% EBITDA mid-FY28–29.
Product strategy in core markets — Rutviz Vora, Vora Investments
AnsweredGathiya is leading product globally and in core markets. Namkeen (sev, murmura, etc.) follows. Focus on potato wafers expansion as secondary push product. Split coverage model in Gujarat (by product category); not yet in Maharashtra (throughput immature).
Guidance
FY27 revenue ₹1,800–1,900 Cr; minimum 20% growth
HighCurrent run rate ₹150+ Cr/month implies ₹450–520 Cr H2; consistent with guidance. Prior guidance withdrawn; now quantified. April disruption risk mitigated by May restart.
Minimum 20% CAGR thereafter (FY28+)
MediumImplied by distributor expansion (1,000+ to 6k+ outlets), geographic footprint (focus → other states), and new products (NPIs). But price-point category headroom limited if inflation persists.
EBITDA margin FY27: 8–9% (exit close to double-digit)
MediumQ1 delivered 7.4%; implies Q2–Q4 needs 8.1–9.2% average. Inflation (5% in Q1, further 0.2–0.3% in Q2) and Rajkot ramp costs remain headwinds. Achievable but tight.
EBITDA margin FY28: 10–11% (exit near 11%)
MediumAssumes Rajkot leverages fully, pricing stabilizes, NPI mix improves. PAT margin ₹7–7.5% guided for FY28, implying tax rate ~30%.
Sustainable EBITDA margin: 11–11.5% (FY28–29 run rate)
LowAmbitious; requires full Rajkot benefit realization, pricing discipline, and cost control. Competitive pressure from regional brands and price-point segment constraints raise execution risk.
Risks the call surfaced
Inflation pass-through
HighQ1 raw material inflation 5%; only 4.2% passed on, 0.8% absorbed. Q2 expects further 0.2–0.3% inflation. Price-point category (₹5 SKU) limits ability to raise prices; grammage reduction is capped before consumer resistance.
Core market saturation
MediumCore state (Gujarat) showed flat QoQ growth in Q1 (despite 31% YoY); April disruption (₹12–13 Cr revenue loss) concentrated in core state. Rajkot restart, double-service model, and DMS are necessary to re-accelerate, but success not yet proven.
Nagpur plant utilization
Medium<30% capacity utilization at Nagpur facility after 2+ years. Logistics optimization (remapping 60 distributors to Modasa) reduces Nagpur volume base structurally. Adding 250 distributors/year vs 300–400 km catchment opportunity gap indicates execution shortfall.
Margin guidance credibility
HighQ1 EBITDA margin 7.4% is below FY27 full-year guidance of 8–9%. To achieve full-year average, Q2–Q4 must average 8.1–9.2%. Rajkot benefit phase-in timing unclear; inflation headwinds persist; management taking 0.8% P&L hit in Q1 and expecting further 0.2–0.3% in Q2.
Price-point category vulnerability
Medium₹5 SKU salience dropped from 80% (FY21–22) to 60% (FY26). Grammage reduction strategy (used twice in Q1) has natural limits before consumer switching. Regional competitors (Balaji, Gokul) still present; national competitors (Lays) active in chips/wafers.
Management
Score 7/10. Clear, data-driven, transparent on challenges (inflation, April disruption, Nagpur underutilization). Specific on product geographies (regional taste nuances), distributor numbers, and run rates. Minimal jargon; Q&A answered substantively. Minor deflection on Maharashtra distributor reduction (initially gave focus/other state numbers instead of Maharashtra specifics). Track record: FY26 saw guidance withdrawal due to force majeure (fire). Now delivering: ₹422.3 Cr Q1 revenue hits claimed 'highest-ever' mark. 5 consecutive quarters of sequential growth credible. Rajkot restart on schedule. However, margin guidance maintained (not upgraded) despite strong revenue, suggesting embedded caution or acceptance of persistent cost headwinds.
1 · Q2 FY27 (Aug–Sep 2026)
Inflation pass-on in pricing/grammage reduction; double-service outlet count acceleration
2 · Sep 2026
First of 5 NPIs (non-palm oil, higher margin) launches across H2 FY27
3 · H2 FY27 (Oct–Mar 2027)
Rajkot facility hits full utilization; logistics consolidation drives cost savings to margin
Key risk: price-point category (₹5 SKU still dominant) limits pricing power as inflation persists.
Record Revenue, but Margins Tell a Different Story
Gopal Snacks delivered highest-ever quarterly revenue of ₹422.3 Cr (+31% YoY), but EBITDA margin lagged guidance at 7.4% vs 8–9%. Inflation and operational disruptions stalled margin expansion despite the revenue beat.
The revenue delivered. The margin didn't.
Gopal Snacks just posted its highest-ever quarterly revenue: ₹422.3 Cr, up 31.1% YoY and 3.1% QoQ. On the headline, it looks crisp. But dial into the margin story, and the quarter shifts from a win into a cautionary tale. EBITDA margin came in at 7.4%, materially below the 8–9% guidance management confirmed for the full year. In a quarter where the Rajkot facility restart was supposed to drive cost leverage, the margin instead compressed. That's the real story.
₹422.3 Cr
+31.1% YoY, +3.1% QoQ
7.4%
+270 bps YoY, but 50–170 bps below FY27 guidance
27%
beat prior guidance of 25–26%
₹12.8 Cr
+409% YoY (headline -57% QoQ masks insurance gain in prior Q)
Why EBITDA missed guidance despite gross margin beat
The margin miss was not a surprise if you listen carefully. Management absorbed 0.8% of margin from a 5% raw material inflation hit in Q1, passing only 4.2% through to consumers. They leaned on price hikes and grammage reduction (tried twice in the quarter) to hold the line. But in a price-point category where the ₹5 SKU still dominates 60% of sales, the levers are finite. Q2 is expected to see another 0.2–0.3% inflation pressure, compounding the margin gap. The Rajkot restart, which management touted as a cost-leverage driver, didn't show enough benefit in Q1 to offset inflation. The plant ramp-up costs are still being absorbed; the benefits phase in gradually over H2.
Despite challenging quarter in terms of significant increase in raw material prices, we were able to maintain a healthy margins through the grammage reduction, better product mix, increase in the prices, and improved manufacturing efficiency.
Translation: we held the line, but we didn't expand. A quarter that should have shown Rajkot benefits instead showed inflation battles—and management is hedging on the margin expansion path with language like 'will continue to ramp gradually' and 'similar steps in Q2.' That's code for: don't expect a quick jump.
Claims vs. what held up
Highest-ever quarterly revenue of ₹422.3 Cr
SupportedExact match to result; confirmed in both results and call
31% YoY, 3% QoQ sequential growth
SupportedExactly 31.1% YoY, 3.1% QoQ as reported
Gross margin 27%, well above guided 25–26%
Supported₹114 Cr gross profit / ₹422.3 Cr = 27.0%; outperformed
Rajkot restart will drive Q2+ margin expansion
OverstatedQ1 EBITDA 7.4% is below 8–9% FY27 guidance; benefits delayed
FY27 minimum 20% revenue growth achievable
Supported₹1,800–1,900 Cr guidance confirmed; ₹150+ Cr/month run rate post-April supports this
QoQ PAT decline is due to prior quarter's insurance gain, not operations
SupportedQ1 core PAT +240% YoY; prior Q had exceptional gain. Headline -57% QoQ is optics
What changed on this call
Guidance re-established. Prior guidance was withdrawn due to supply chain disruption. Now: FY27 ₹1,800–1,900 Cr (minimum 20% growth), ₹150+ Cr/month current run rate. De-risked execution post-April reset.
Margin guidance maintained, not raised. Despite beating gross margin, EBITDA guidance stayed 8–9% for FY27. Signal: management either expects inflation to persist or has embedded headwinds they're not flagging. Conservative posture.
Distributor base and retail expansion confirmed. Focus-state distributors: 567 (vs 530 in Q4). Retail touchpoints: 424k (target 600k by year-end, +41%). 1,000+ distributors across network. Distribution moat is real.
The bull-bear ledger
Highest-ever revenue confirms operational turnaround after FY26 fire and disruptions
Gross margin beat (27% vs 25–26%) shows pricing and mix control despite inflation
Distribution scale (1,000+ distributors, 5.25–5.5 lakh outlets) is a structural moat vs. regional competitors
EBITDA margin guidance (8–9% FY27) vs. Q1 delivery (7.4%) signals execution gap or embedded inflation risk
Inflation pass-through incomplete (4.2% of 5% in Q1, 0.2–0.3% more in Q2); grammage lever has limits
Core market (Gujarat) flat QoQ; April disruption (₹12–13 Cr loss) shows operational fragility
₹5 SKU still 60% of sales; limited pricing power in price-point category if inflation accelerates
FY27 EBITDA margin exit 8–9% requires 40–170 bps expansion Q2–Q4; achievable but tight
Risks, ranked by holder concern
Margin guidance credibility
HighQ1 EBITDA 7.4% vs FY27 guidance 8–9% means Q2–Q4 must average 8.1–9.2%. Rajkot costs still phase-in; benefits lagging. If inflation persists, guidance slips.
Inflation pass-through incomplete
HighQ1 absorbed 0.8% margin (5% inflation, 4.2% passed through), with 0.2–0.3% more in Q2. ₹5 SKU limits pricing; grammage reduction tried twice already. Margin erosion risk.
Core market saturation and April disruption
MediumGujarat flat QoQ despite 31% YoY; April loss of ₹12–13 Cr concentrated in core state. Shows operational fragility in highest-margin market.
Nagpur facility underutilization
Medium<30% capacity utilization after 2+ years. Remapped ~60 distributors to Modasa for cost savings, structurally reducing addressable base. Capex ROI remains poor.
Price-point category dependency
Medium₹5 SKU 60% of sales (down from 80% in FY21–22). If competitors pressure pricing and inflation forces further hikes, volume headwind. NPI mix shift (₹23–24 Cr in Q1 vs ₹422.3 Cr total) is immaterial so far.
How the street is positioned
Price action: The stock fell 1.55% on day 1 post-announcement, and the decline didn't recover. By day 3, still down 1.28%, with 54% delivery—institutional sellers dominated. Market verdict: revenue beat, margin miss. Exact read this analysis supports.
Valuation and drawdown: At ₹276.65, Gopal trades 24% below its all-time high of ₹364.4, but 11.4% above the 52-week low of ₹248.35. Above SMA20 and SMA50, but below SMA200 (₹297.08). RSI at 70.7 signals overbought—despite margin disappointment, the stock is technically extended. The market ran ahead on revenue and hasn't fully priced margin execution risk.
Institutional flows: FII ownership tumbled to 0.76% from 1.42% a year ago—a 66 basis-point retreat. DII flat (~6%). Promoter rock-solid at 81.45%. The FII exit after the stock ran from ₹248 to ₹364 is a yellow flag: foreign investors taking profits, not adding on recovery. Contrasts with domestic positioning, suggesting global skepticism on margin sustainability.
What to watch next
1 · Q2 margin trajectory
Can Gopal expand EBITDA toward 8–9% guidance, or does 0.2–0.3% more inflation keep it pinned below 7.5%? Rajkot ramp benefits must become visible, or full-year guidance slips. Make-or-break metric for credibility.
2 · Core market growth reacceleration
Gujarat flat QoQ in Q1 despite ₹150+ Cr/month May–Jun run rate. Can double-service (38% of outlets) and DMS drive core growth back to +5–10% QoQ, or does competitive pressure keep it flat? Matters because core state is highest-margin.
3 · Non-palm oil product (NPI) launch and mix shift
Five of seven NPIs launching in Q2–Q3. Higher-margin products. If NPI revenue reaches ₹30–50 Cr run-rate by Q3, mix effect could drive 50–100 bps EBITDA expansion independent of Rajkot. Upside wildcard.
The single number to track from here
FY27 EBITDA margin exit. If Gopal reaches 8–9% (as guided) by Q4, the Rajkot story holds, inflation is managed, and the 20%+ revenue growth + margin-expansion narrative is intact. If it stays 7–7.5%, inflation won. Everything else follows from margin. Track Q2 and Q3 EBITDA closely; they're the bellwether.
Gopal Snacks delivered the revenue. It didn't deliver the margin. That's not failure—it's a reset of expectations. The company is executing on the turnaround (₹422.3 Cr highest-ever revenue is proof), but inflation has temporarily stalled the margin expansion that was supposed to come from Rajkot. Management is holding the line, not breaking it. The street's reaction—a small down-move that didn't recover—suggests skepticism of the margin guidance, and the FII trimming echoes that. Steady execution is valuable in a turnaround, but it's not a reason to buy higher. Wait for Q2 to confirm whether margins can re-inflect, or stay on the sidelines. The debate turns on one thing: can Rajkot benefits outrun inflation. In Q1, they didn't.